8th April 2020: NICE has developed a medtech innovation briefing (MIB) on Lifelight First for monitoring vital signs NICE MEDTECH INNOVATION BRIEFING SUMMARY: The technology described in this briefing is Lifelight First. It is used for measuring indicative estimates of blood pressure (mmHg), pulse rate (beats per minute), and respiration rate (respirations per [...]
2nd April 2020: Lifelight is currently being trialled at St Clements Practice, Winchester to support assessment of patients with suspected COVID-19 Lifelight measures blood pressure, heart rate and respiratory rate aiding the assessment of these potentially unwell patients while reducing the need for contact between healthcare professional and patient as well as cross-contamination [...]
30th March 2020: Digital Health London Accelerator's SME of the Week is xim Limited, creators of Lifelight. Lifelight measures the key vital signs which are critical to COVID-19 detection DigitalHealth.London Accelerator’s SME of the Week is Xim Limited, creators of Lifelight. Lifelight measures the key vital signs which are critical to COVID-19 detection [...]
26th March 2020: Research Paper Abstract: The measurement of Vital Signs by Lifelight® software in comparison to standard of care – The VISION D Study An Analysis of Lifelight First performance in real-world clinical use Dr Melissa Kapoor - Mind Over Matter Medtech Limited BACKGROUND: Lifelight First is a [...]
23rd March 2020: UK-based xim Limited, creators of Lifelight are supporting the call from the World Health Organisation to “test, test, test…” in the wake of the Coronavirus epidemic Lifelight is the only data validated - recording over 1 million heartbeats – CE Marked - Vital Signs technology that allows anyone to easily [...]
4th February 2020: Brand new episode of the Innovation Exchange podcast on cardiovascular health is out now! Oxford Academic Health Science Network (Oxford AHSN) CEO Gary Ford covers the key challenges facing the NHS, plus hear from leading innovators, including our CEO & Founder, Laurence Pearce. Listen from 16.29 minutes onwards to hear [...]
